Viking Therapeutics, Inc. (VKTX)
32.98
+1.47
(+4.67%)
USD |
NASDAQ |
Mar 06, 16:00
33.00
+0.02
(+0.06%)
After-Hours: 20:00
Viking Therapeutics SG&A Expense (TTM) : 48.39M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Amgen, Inc. | 7.05B |
| Pfizer Inc. | 13.79B |
| Hims & Hers Health, Inc. | 1.192B |
| Altimmune, Inc. | 28.10M |